Ilona Behrendt

598 total citations
9 papers, 442 citations indexed

About

Ilona Behrendt is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Ilona Behrendt has authored 9 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Infectious Diseases. Recurrent topics in Ilona Behrendt's work include Viral Infectious Diseases and Gene Expression in Insects (8 papers), Virus-based gene therapy research (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Ilona Behrendt is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (8 papers), Virus-based gene therapy research (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Ilona Behrendt collaborates with scholars based in Germany. Ilona Behrendt's co-authors include Yvonne Genzel, Udo Reichl, H. Sann, Susanne König, Ingo Jordan, Thomas Vogel, Gudrun Schiedner, Verena Lohr, Dietrich Flockerzi and Timo Frensing and has published in prestigious journals such as PLoS ONE, Applied Microbiology and Biotechnology and Vaccine.

In The Last Decade

Ilona Behrendt

9 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilona Behrendt Germany	8	280	178	172	147	50	9	442
Verena Lohr Germany	8	202 0.7×	92 0.5×	155 0.9×	105 0.7×	21 0.4×	13	298
Jelena Ivančić-Jelečki Croatia	14	180 0.6×	237 1.3×	63 0.4×	141 1.0×	37 0.7×	36	493
Sascha Young Kupke Germany	11	147 0.5×	223 1.3×	85 0.5×	124 0.8×	16 0.3×	16	402
Jörg Zielonka Germany	11	105 0.4×	233 1.3×	148 0.9×	78 0.5×	40 0.8×	11	427
Margret Nathan Israel	8	182 0.7×	222 1.2×	107 0.6×	172 1.2×	23 0.5×	8	471
Danielle Jacob Canada	13	474 1.7×	101 0.6×	341 2.0×	151 1.0×	15 0.3×	16	585
Thy T. Follmer United States	3	218 0.8×	57 0.3×	104 0.6×	113 0.8×	19 0.4×	6	384
Stéphane Lanthier Canada	13	428 1.5×	55 0.3×	294 1.7×	112 0.8×	27 0.5×	16	548
Alicia Hurtado United States	11	161 0.6×	47 0.3×	213 1.2×	121 0.8×	17 0.3×	17	383
Alan Yung-Chih Hu Taiwan	10	115 0.4×	192 1.1×	47 0.3×	125 0.9×	26 0.5×	21	323

Countries citing papers authored by Ilona Behrendt

Since Specialization

Citations

This map shows the geographic impact of Ilona Behrendt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilona Behrendt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilona Behrendt more than expected).

Fields of papers citing papers by Ilona Behrendt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilona Behrendt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilona Behrendt. The network helps show where Ilona Behrendt may publish in the future.

Co-authorship network of co-authors of Ilona Behrendt

This figure shows the co-authorship network connecting the top 25 collaborators of Ilona Behrendt. A scholar is included among the top collaborators of Ilona Behrendt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilona Behrendt. Ilona Behrendt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Tapia, Felipe, et al.. (2020). Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production. Biotechnology Journal. 16(1). e2000024–e2000024. 15 indexed citations

Behrendt, Ilona, et al.. (2019). Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems. Vaccine. 37(47). 7011–7018. 23 indexed citations

Genzel, Yvonne, Thomas Vogel, Ilona Behrendt, et al.. (2014). High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells. Vaccine. 32(24). 2770–2781. 75 indexed citations

Frensing, Timo, Frank S. Heldt, Ilona Behrendt, et al.. (2013). Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering Particles. PLoS ONE. 8(9). e72288–e72288. 77 indexed citations

Tapia, Felipe, Thomas Vogel, Yvonne Genzel, et al.. (2013). Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor. Vaccine. 32(8). 1003–1011. 39 indexed citations

Genzel, Yvonne, Ilona Behrendt, Erdmann Rapp, et al.. (2012). CAP, a new human suspension cell line for influenza virus production. Applied Microbiology and Biotechnology. 97(1). 111–122. 37 indexed citations

Genzel, Yvonne, Thomas Vogel, Ilona Behrendt, et al.. (2012). High cell density cultivations for influenza virus production using suspension cells. Max Planck Institute for Plasma Physics. 1 indexed citations

Lohr, Verena, et al.. (2010). A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor. Vaccine. 28(38). 6256–6264. 61 indexed citations

Genzel, Yvonne, Ilona Behrendt, Susanne König, H. Sann, & Udo Reichl. (2003). Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine. 22(17-18). 2202–2208. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact